Primatene HFA Turned Down By FDA Panel; Will Capitol Hill Accept Decision?
This article was originally published in RPM Report
Executive Summary
The Primatene Mist phase-out has been a topic of interest for one prominent Republican Congressman, Texas’ Michael Burgess. He’s been eager for FDA to approve a replacement, but Armstrong’s reformulation doesn’t look ready just yet. In an interview, Burgess says he won’t tell FDA what to do – but will keep a close eye just the same.